c-Met-IN-1
≥98%
- Product Code: 107965
CAS:
2084836-84-8
| Molecular Weight: | 640.7 g./mol | Molecular Formula: | C₃₅H₃₇FN₆O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used primarily in cancer research, this compound acts as an inhibitor targeting the c-Met receptor tyrosine kinase. It is applied in studies to understand and disrupt signaling pathways involved in tumor growth and metastasis. Researchers utilize it to explore potential therapeutic strategies for cancers where c-Met overexpression or mutation plays a critical role, such as in certain types of lung, liver, and gastric cancers. Its ability to block c-Met activity helps in assessing the receptor's role in cancer progression and in evaluating the efficacy of targeted treatments.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $2,260.17 |
+
-
|
c-Met-IN-1
Used primarily in cancer research, this compound acts as an inhibitor targeting the c-Met receptor tyrosine kinase. It is applied in studies to understand and disrupt signaling pathways involved in tumor growth and metastasis. Researchers utilize it to explore potential therapeutic strategies for cancers where c-Met overexpression or mutation plays a critical role, such as in certain types of lung, liver, and gastric cancers. Its ability to block c-Met activity helps in assessing the receptor's role in cancer progression and in evaluating the efficacy of targeted treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :